Shree Ganesh Remedies Ltd
BSE:540737
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| IN |
|
Shree Ganesh Remedies Ltd
BSE:540737
|
6.1B INR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
871.6B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.1B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
231.4B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.9B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
231.4B CHF |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
155.5B USD |
Loading...
|
|
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
89.3B GBP |
Loading...
|
Market Distribution
| Min | -3 052.3% |
| 30th Percentile | 26.9% |
| Median | 39% |
| 70th Percentile | 53.3% |
| Max | 8 269.1% |
Other Profitability Ratios
Shree Ganesh Remedies Ltd
Glance View
Shree Ganesh Remedies Ltd. engages in the research, development, manufacture, and marketing of healthcare products. The company is headquartered in Ankleshwar, Gujarat. The company went IPO on 2017-10-13. The firm is a supplier of pharmaceutical intermediates and specialty chemicals with chlorination, grignard reaction, hydrogenation and high-vacuum distillation. Its products include intermediates by active pharmaceutical ingredient (API), and fine and specialty chemicals. The company offers services, including customized chemistry and manufacturing, assets and infrastructure and key technologies and expertise. The company also delivers service of contract manufacturing for chemical reactions like amination, amidation, alkylation, bromination, catalytic hydrogenation and chlorination. The firm's subsidiaries include Akshar Jyot Private Limited and Dhari Chemicals Limited.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Shree Ganesh Remedies Ltd is 66.7%, which is above its 3-year median of 56.9%.
Over the last 3 years, Shree Ganesh Remedies Ltd’s Gross Margin has increased from 47.4% to 66.7%. During this period, it reached a low of 46.7% on Sep 30, 2023 and a high of 66.7% on Jan 1, 2026.
